• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗现场研究的设计与解读

Design and interpretation of vaccine field studies.

作者信息

Halloran M E, Longini I M, Struchiner C J

机构信息

Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.

出版信息

Epidemiol Rev. 1999;21(1):73-88. doi: 10.1093/oxfordjournals.epirev.a017990.

DOI:10.1093/oxfordjournals.epirev.a017990
PMID:10520474
Abstract

There are many different effects to consider when evaluating vaccines in the field. In this review, we have covered some of the various measures and issues related to study design and interpretation of the different measures. We emphasize that in designing and understanding vaccine studies, it is necessary to be specific about what the effect of interest is and about the assumptions underlying the interpretation of the results. Halloran et al. (81) present design, analysis, and interpretation of vaccine studies in more detail.

摘要

在实地评估疫苗时,有许多不同的效应需要考虑。在本综述中,我们涵盖了一些与研究设计以及不同测量方法的解读相关的各种措施和问题。我们强调,在设计和理解疫苗研究时,必须明确所关注的效应是什么,以及结果解读所依据的假设是什么。哈洛伦等人(81)更详细地介绍了疫苗研究的设计、分析和解读。

相似文献

1
Design and interpretation of vaccine field studies.疫苗现场研究的设计与解读
Epidemiol Rev. 1999;21(1):73-88. doi: 10.1093/oxfordjournals.epirev.a017990.
2
[Design of field studies on vaccines which involves capturing indirect effect].[涉及捕捉间接效应的疫苗现场研究设计]
Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Feb;32(2):182-6.
3
On measures and models for the effectiveness of vaccines and vaccination programmes.关于疫苗及疫苗接种计划有效性的衡量方法和模型
Int J Epidemiol. 1988 Jun;17(2):456-63. doi: 10.1093/ije/17.2.456.
4
Study designs for evaluating different efficacy and effectiveness aspects of vaccines.用于评估疫苗不同效力和效果方面的研究设计。
Am J Epidemiol. 1997 Nov 15;146(10):789-803. doi: 10.1093/oxfordjournals.aje.a009196.
5
A framework for research on vaccine effectiveness.疫苗效力研究框架。
Vaccine. 2018 Nov 19;36(48):7286-7293. doi: 10.1016/j.vaccine.2018.04.016. Epub 2018 Oct 26.
6
Evaluating the Effectiveness of Vaccines Using a Regression Discontinuity Design.利用回归不连续设计评估疫苗的有效性。
Am J Epidemiol. 2019 Jun 1;188(6):987-990. doi: 10.1093/aje/kwz043.
7
Vaccine strategies: Optimising outcomes.疫苗策略:优化结果。
Vaccine. 2016 Dec 20;34(52):6691-6699. doi: 10.1016/j.vaccine.2016.10.078. Epub 2016 Nov 23.
8
Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.针对婴儿、儿童、青少年及成人的免疫规划:美国传染病学会临床实践指南
Clin Infect Dis. 2009 Sep 15;49(6):817-40. doi: 10.1086/605430.
9
Adult immunization in India: Importance and recommendations.印度的成人免疫接种:重要性与建议。
Hum Vaccin Immunother. 2015;11(9):2180-2. doi: 10.4161/hv.29342. Epub 2014 Jun 18.
10
SAFETY OF SABIN ORAL POLIOVACCINE STRAINS; MASS IMMUNIZATION PROGRAM IN LOS ANGELES COUNTY, 1962-1963.萨宾口服脊髓灰质炎疫苗株的安全性;1962 - 1963年洛杉矶县大规模免疫计划
JAMA. 1963 Nov 30;186:821-6.

引用本文的文献

1
Clade I mpox vaccination: strategies for deployment and evaluation.第一分支猴痘疫苗接种:部署与评估策略
EBioMedicine. 2025 Aug 20;119:105890. doi: 10.1016/j.ebiom.2025.105890.
2
Rates of SARS-CoV-2 Breakthrough Infection or Severe COVID-19 and Associated Risk Factors After Primary and Booster Vaccination Against COVID-19 in the Netherlands.荷兰接种新冠疫苗初种和加强针后新冠病毒突破性感染或重症新冠肺炎的发生率及相关风险因素
Vaccines (Basel). 2025 May 26;13(6):564. doi: 10.3390/vaccines13060564.
3
Vaccine failure mode determines population-level impact of vaccination campaigns during epidemics.
疫苗失效模式决定了疫情期间疫苗接种运动对人群层面的影响。
J R Soc Interface. 2025 Feb;22(223):20240689. doi: 10.1098/rsif.2024.0689. Epub 2025 Feb 19.
4
The need for a clinical case definition in test-negative design studies estimating vaccine effectiveness.在估计疫苗效力的检测阴性设计研究中对临床病例定义的需求。
NPJ Vaccines. 2023 Aug 12;8(1):118. doi: 10.1038/s41541-023-00716-9.
5
Revisiting assumptions in test-negative studies for estimating vaccine effectiveness: the need for a clinical case definition.重新审视用于评估疫苗效力的检测阴性研究中的假设:临床病例定义的必要性。
Res Sq. 2023 May 4:rs.3.rs-2689147. doi: 10.21203/rs.3.rs-2689147/v1.
6
Public Health Impacts of Vaccines for COVID-19 and Beyond: Opportunities to Overcome Technical and Regulatory Barriers for Randomized Trials.新冠疫苗和其他疫苗的公共卫生影响:克服随机试验技术和监管障碍的机会。
Am J Public Health. 2023 Jul;113(7):778-785. doi: 10.2105/AJPH.2023.307302. Epub 2023 Apr 27.
7
Testing Whether Higher Contact Among the Vaccinated Can Be a Mechanism for Observed Negative Vaccine Effectiveness.检测接种者之间更高的接触是否可以成为观察到的负面疫苗效力的一种机制。
Am J Epidemiol. 2023 Aug 4;192(8):1335-1340. doi: 10.1093/aje/kwad055.
8
Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal.奥密克戎 BA.5 和 BA.2 亚型株新冠病毒感染和疾病进展的预防:葡萄牙的 COVID-19 疫苗比较效果
Emerg Infect Dis. 2023 Mar;29(3):569-575. doi: 10.3201/eid2903.221367. Epub 2023 Feb 3.
9
Disentangling the causes of mumps reemergence in the United States.解析美国流行性腮腺炎再现的原因。
Proc Natl Acad Sci U S A. 2023 Jan 17;120(3):e2207595120. doi: 10.1073/pnas.2207595120. Epub 2023 Jan 9.
10
Prioritizing interventions for preventing COVID-19 outbreaks in military basic training.优先考虑干预措施,以预防军事基础训练中的 COVID-19 疫情。
PLoS Comput Biol. 2022 Oct 7;18(10):e1010489. doi: 10.1371/journal.pcbi.1010489. eCollection 2022 Oct.